Website Logo
Website Logo
Spotlight
COVID-19Sickle Cell Disease
Clinical
View MoreADHDAllergyArterial DiseaseCardiologyDermatologyDiabetesGastroenterologyGeriatric MedicineInfectious DiseaseInflammationNeurologyPsychiatryPulmonologyRheumatology
Video Series
InsightsNews NetworkPeers & PerspectivesPost Conference Perspectives
News
Media
Medical World News
Peer Exchange
Podcasts
Videos
Webinars
Conferences
Conference Coverage
Conference Listing
PartnersCME/CE
Resources
Exclusive Content
Interactive Tools
Live Events
Press Release
Publications
Sponsored
Subscribe
Spotlight
  • COVID-19
  • Sickle Cell Disease
ClinicalSee All >
  • ADHD
  • Allergy
  • Arterial Disease
  • Cardiology
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Geriatric Medicine
  • Infectious Disease
  • Inflammation
  • Neurology
  • Psychiatry
  • Pulmonology
  • Rheumatology
Video Series
  • Insights
  • News Network
  • Peers & Perspectives
  • Post Conference Perspectives
hcplive podcasts
  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.

Paradigm Shift in Lipid Management

EP. 1: Guidelines to Manage Blood Cholesterol

October 9th 2020

EP. 2: Targeting LDL Cholesterol

October 9th 2020

EP. 3: Coronary Calcium Scoring to Assess Cardiovascular Risk

October 9th 2020

EP. 4: Disparities in Lipid Management

October 9th 2020

EP. 5: Statin Therapy Selection and Shared Decision-Making

October 9th 2020

EP. 6: Management of Statin Intolerance/Myalgias

October 9th 2020

EP. 7: Ezetimibe to Help Lower LDL-C

October 9th 2020

EP. 8: Bempedoic Acid to Reduce LDL-C

October 9th 2020

EP. 9: Icosapent Ethyl for Cardiovascular Risk

October 9th 2020

EP. 10: PCSK9 Inhibitors to Help Lower LDL-C

October 9th 2020

Latest News

Jennifer Green, MD: Outcomes, Impact of SGLT2i, GLP-1 RA Combination Therapy

Joshua J. Joseph, MD: Managing CV Risk Factors in Patients with Type 2 Diabetes

Antirituximab Antibodies Detected in Patients with Pemphigus

View More News